Core Viewpoint - Shurui Robotics has successfully obtained CE certification for its snake-arm single-port surgical robot, marking a significant milestone in its international expansion and establishing itself as a leader in minimally invasive surgical technology [1][6][15] Group 1: Product Development and Innovation - The snake-arm single-port surgical robot represents a breakthrough in surgical technology, allowing for high degrees of freedom and precision through a single small incision, thus reducing patient trauma and recovery time [5][6] - The robot has surpassed the capabilities of traditional multi-port surgical robots, enabling complex surgeries that previously required multiple incisions to be performed through a single small incision [5][6] Group 2: Clinical Applications and Achievements - The robot is approved for use in various surgical fields, including urology, gynecology, general surgery, thoracic surgery, and pediatric surgery, making it the first Chinese surgical robot approved for all demographics in the EU [1][8] - Shurui Robotics has established clinical partnerships with over 70 hospitals in mainland China and nearly 10 in Europe, completing over 2,000 surgeries and validating its performance in safety, adaptability, and precision [8][9] Group 3: International Expansion and Collaboration - The company has begun to actively expand into the European market, forming collaborations with experts in Germany, Spain, France, and Italy, and establishing a clinical excellence center in partnership with IRCAD [9][10] - A landmark event occurred when a renowned thoracic surgeon in Spain successfully performed the world's first remote single-port thoracic surgery using the Shurui robot, showcasing its advanced capabilities [10] Group 4: Future Vision and Goals - Shurui Robotics aims to promote its original technology globally, focusing on expanding its registration and clinical applications in more countries and regions, thereby providing more patients with minimally invasive and precise surgical solutions [15]

Core Insights - The successful completion of China's first single-port robot-assisted thyroid cancer surgery marks a significant advancement in minimally invasive surgical techniques for thyroid tumors [1][2] - The use of the domestically developed Shuri snake-arm robot demonstrates the integration of innovative technology in clinical practice, aligning with China's "Healthy China" strategy [3] Surgical Technique and Advantages - The surgery was performed through a single 2.5 cm incision in the axilla, which is concealed in the natural folds, resulting in minimal scarring and meeting patient aesthetic demands [3] - The snake-arm robot offers 360° maneuverability, allowing for precise dissection around critical structures, thus avoiding the "chopstick effect" and minimizing intraoperative bleeding to under 10 ml [3] - The 3D endoscope provides a 10x magnified view and advanced tremor filtering technology, enabling sub-millimeter precision in surgical operations, effectively protecting surrounding tissues [3] Patient Outcomes - The patient experienced rapid recovery, being able to mobilize the next day without complications such as hoarseness or numbness, and stable blood calcium levels were maintained [3] - Pathological results confirmed negative margins and thorough lymph node clearance, meeting the standards for tumor eradication [3] Industry Implications - The success of this surgery exemplifies the capabilities of domestic surgical robot technology and highlights the potential for reshaping the future of surgical practices with a focus on precision, minimally invasive techniques, and accessibility [3]